Target intelligence / Profile preview

Gram-positive bacterial cell wall and cytoplasmic membrane (None)

Target
None
Molecular classification
Bacterial cell envelope, Peptidoglycan, Lipid bilayer
01

Overview

The Gram-positive bacterial cell wall and cytoplasmic membrane together form the cell envelope, a critical structure for maintaining bacterial viability and shape. The cell wall is composed of a thick, cross-linked peptidoglycan layer that provides structural rigidity and protects the bacterium from osmotic lysis (Silhavy et al., 2010). This layer is often associated with teichoic acids, which contribute to the cell's surface charge and play roles in pathogenesis. Beneath the peptidoglycan lies the cytoplasmic membrane, a selective permeability barrier that facilitates energy production and nutrient transport (Breijyeh et al., 2020). These structures are major targets for antimicrobial therapy because they are essential for bacteria and significantly different from human cellular components. Beta-lactam antibiotics, such as penicillins, inhibit the transpeptidase enzymes responsible for peptidoglycan cross-linking, while glycopeptides like vancomycin bind directly to cell wall precursors (Scheffers & Pinho, 2005). Additionally, lipopeptides like daptomycin target the cytoplasmic membrane, causing rapid depolarization and cell death (Taylor & Palmer, 2016).

Other names
Gram-positive cell envelopeBacterial cell wallPeptidoglycan layerMurein layerCytoplasmic membrane
02

Mechanism of action

Inhibition of peptidoglycan cross-linking (transpeptidation), binding to D-alanyl-D-alanine cell wall precursors, and disruption of the cytoplasmic membrane potential through pore formation or depolarization.

03

Biological functions

Structural integrityOsmotic protectionCell divisionSelective permeabilityIon homeostasisCellular signaling
04

Disease associations

Bacterial infectionSepsisPneumoniaEndocarditisSkin and soft tissue infection
05

Safety considerations

Antimicrobial resistance (e.g., MRSA, VRE)Hypersensitivity and anaphylaxisNephrotoxicityOtotoxicityDisruption of the normal human microbiome
06

Interacting drugs

Penicillin G

7 more in the full profile.

07

Biomarkers

Gram stainBacterial culture and sensitivityProcalcitonin levelsC-reactive protein (CRP)

Beyond the preview

Go deeper on Gram-positive bacterial cell wall and cytoplasmic membrane (None).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gram-positive bacterial cell wall and cytoplasmic membrane (None).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call